Medreich Limited
Indian Pharmaceutical Exporter · Antibiotics Specialist · $224.8M Total Trade · DGFT Verified
Medreich Limited is an Indian pharmaceutical exporter with a total trade value of $224.8M across 42 products in 15 therapeutic categories. Based on 7,285 verified export shipments from Indian Customs (DGFT) records, Medreich Limited is the #1 Indian exporter in 2 products including Flucloxacillin, Benzylpenicillin. Top exports include Amoxicillin ($47.7M), Potassium ($20.9M), Flucloxacillin ($16.9M).
Medreich Limited — Export Portfolio & Destination Treemap

Who is Medreich Limited? — Company Overview & Market Position
Medreich Limited, established on August 16, 1973, in Bengaluru, Karnataka, India, is a fully integrated pharmaceutical company specializing in contract manufacturing and development of pharmaceutical preparations across various dosage forms. The company operates under the Corporate Identification Number (CIN) U24232KA1973PLC002383. Medreich's authorized capital stands at ₹160.50 crore, with a paid-up capital of ₹40.16 crore.
In 2015, Medreich became a subsidiary of the Meiji Group, a leading Japanese conglomerate listed on the Tokyo Stock Exchange, with business interests spanning pharmaceuticals, food, and nutrition products. The company employs approximately 3,000 individuals worldwide, providing a robust platform for employee growth and development.